Short QT Interval Prevalence and Clinical Outcomes in a Pediatric Population
Karine Guerrier1, David Kwiatkowski2, Richard J Czosek2
1From the Department of Cardiology, Cincinnati Children's Hospital Medical Center, The Heart Institute, OH (K.G., R.J.C., D.S.S., J.B.A., T.K.K.); and Department of Cardiology, The Heart Center, Lucile Packard Children's Hospital, Palo Alto, CA (D.K.). Karine.Guerrier@cchmc.org.
Insights
Short QT interval is rare in children, affecting 0.05% of patients. This study found no unifying clinical characteristics for pediatric patients with short QT intervals, though males predominated.
Area of Science:
- Cardiology
- Pediatric Electrophysiology
Background:
- Short QT interval (SQT) risk is recognized, but pediatric prevalence data are limited.
- European adult studies report SQT prevalence from 0.02% to 0.1%.
- This study addresses the gap in pediatric SQT prevalence research.
Purpose of the Study:
- To determine the prevalence of short QT interval in a pediatric population.
- To identify associated clinical characteristics and outcomes in pediatric patients with SQT.
- To compare symptomatic and asymptomatic pediatric patients with SQT.
Main Methods:
- Retrospective review of ECGs from a single pediatric institution.
- Database query for patients ≤21 years with QTc 140-340 ms, confirmed by pediatric electrophysiologist.
- Chart review for clinical characteristics, symptoms, and outcomes; comparison of symptomatic vs. asymptomatic groups.
Main Results:
- Prevalence of short QT interval (QTc ≤340 ms) was 0.05% (45/99,380 patients).
- Median age was 15 years; median QTc was 323 ms.
- Women had significantly shorter QTc than men (312 vs. 323 ms; P=0.03). Two deaths occurred (respiratory failure, unknown cause with dilated cardiomyopathy).
Conclusions:
- Short QT interval is a rare finding in pediatric patients (0.05% prevalence).
- Male predominance was observed, but women had shorter QTc intervals.
- No unifying clinical characteristics were identified for this pediatric SQT cohort.
Background:
Risk associated with short QT interval has recently received recognition. European studies suggest a prevalence of 0.02% to 0.1% in the adult population, but similar studies in pediatric patients are limited. We sought to determine the prevalence of short QT interval in a pediatric population and associated clinical characteristics and outcomes.
Methods And Results:
Retrospective review of an ECG database at a single pediatric institution. The database was queried for ECGs on patients ≤21 years with electronically measured QTc of 140 to 340 ms. Patients with QTc of 140 to 340 ms confirmed by a pediatric electrophysiologist were identified for chart review for associated clinical characteristics, symptoms, and outcome. Patients with and without symptoms were compared in an attempt to identify variables associated with outcome. The query included 272 504 ECGs on 99 380 unique patients. Forty-five patients (35 men, 76%) had QTc ≤340 ms, for a prevalence of 0.05%. Median age was 15 years (interquartile range, 2-17), median QT 330 ms (interquartile range, 280-360), and median QTc 323 ms (IQR, 313-332). Women had significantly shorter QTc compared with men (312 versus 323 ms; P=0.03). Two deaths were noted in chart review--one from respiratory failure and the second of unknown pathogenesis in a patient with dilated cardiomyopathy.
Conclusions:
Short QT interval was a rare finding in this pediatric population, with a prevalence of 0.05%. Male predominance was identified, although the median QT interval was significantly shorter in women. There seem to be no unifying clinical characteristics for this pediatric patient cohort with short QT interval.
More Related Videos
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)